US Inhaled Insulin Therapeutic Choice Questionnaire Study

NCT00139763 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
740
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer

Collaborators